Fast heart and vessel check for people on immune cancer drugs
Part of Cancer clinical trials.
This trial looks at a faster heart and blood-vessel assessment for people who are taking immune cancer drugs and have been referred because they might be having a heart-related side effect. It may help by speeding up evaluation and treatment decisions when symptoms raise concern.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are taking immune checkpoint inhibitor cancer treatment (immune cancer drugs).
- A clinician referred you to a cardio-oncology (heart + cancer) unit for suspected heart or blood-vessel complications.
- The concern is specifically related to possible immune-related heart effects from your cancer treatment.
- You have been evaluated or are being evaluated for “suspected cardiovascular event” symptoms or findings.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how a special heart clinic can help cancer patients avoid or manage heart problems caused by their cancer treatment. It aims to find the best ways to detect, prevent, and treat heart issues during cancer care.
This study watches heart health in people starting immunotherapy (a cancer treatment that boosts the immune system) by checking blood samples for heart-related markers. It aims to find early signs of heart problems so they can be managed sooner.
This trial looks at whether immunotherapy drugs (checkpoint inhibitors) cause heart problems in people with certain cancers. It will help doctors understand who is at risk and how to monitor for side effects.
This trial tests an early heart-focused intervention guided by a special heart recording (impedance cardiography) in people with locally advanced, unresectable stage III non-small cell lung cancer. The goal is to improve heart-related safety during planned radiation and chemotherapy, with or without immunotherapy.
This study looks at how targeted cancer treatments affect the heart. If you are an adult with any type of cancer and are getting or will get chemotherapy (including targeted drugs), joining this study helps doctors understand heart risks better.
This study looks at whether doctors can predict heart problems caused by certain cancer treatments. It gathers information from patients before they start treatment to build better risk-checking tools.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.